Cargando…

Treatment stratification and prognosis assessment using circulating tumor DNA in locally advanced rectal cancer: A systematic review and meta‐analysis

BACKGROUND: Circulating tumor DNA (ctDNA) is an emerging biomarker for locally advanced rectal cancer (LARC), giving hope for stratified treatment. As the completed studies have small sample sizes and different experimental methods, systematic review and meta‐analysis were performed to explore their...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mi, Junjie, Wang, Rong, Han, Xiaofang, Ma, Ruijun, Zhao, Danyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523996/ https://www.ncbi.nlm.nih.gov/pubmed/37553845 http://dx.doi.org/10.1002/cam4.6434

Ejemplares similares

Circulating tumor DNA predicts recurrence and assesses prognosis in operable gastric cancer: A systematic review and meta-analysis
por: Mi, Junjie, et al.
Publicado: (2023)

Diagnostic Accuracy of Wireless Capsule Endoscopy in Polyp Recognition Using Deep Learning: A Meta-Analysis
por: Mi, Junjie, et al.
Publicado: (2022)

Diagnostic accuracy of probe-based confocal laser endomicroscopy and tissue sampling by endoscopic retrograde cholangiopancreatography in indeterminate biliary strictures: a meta‑analysis
por: Mi, Junjie, et al.
Publicado: (2022)

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
por: Sclafani, Francesco, et al.
Publicado: (2018)

Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy
por: Zhang, Lu-Ning, et al.
Publicado: (2015)

Circulating tumour DNA in the evolving treatment landscape of locally advanced rectal cancer: where does it fit in?
por: Piercey, Oliver, et al.
Publicado: (2023)

Circulating APRIL levels are correlated with advanced disease and prognosis in rectal cancer patients
por: Lascano, V, et al.
Publicado: (2015)

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non–Small Cell Lung Cancer
por: Pellini, Bruna, et al.
Publicado: (2023)

Response prediction and risk stratification of patients with rectal cancer after neoadjuvant therapy through an analysis of circulating tumour DNA
por: Liu, Wenyang, et al.
Publicado: (2022)

The Role of Micro-RNAs and Circulating Tumor Markers as Predictors of Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer
por: De Palma, Fatima Domenica Elisa, et al.
Publicado: (2020)

Novel biomarkers to predict treatment response and prognosis in locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy
por: Guan, Bingjie, et al.
Publicado: (2023)

CEA Decline Predicts Tumor Regression and Prognosis in Locally Advanced Rectal Cancer Patients with Elevated Baseline CEA
por: Cai, Zerong, et al.
Publicado: (2020)

Retrospective research of neoadjuvant therapy on tumor-downstaging, post-operative complications, and prognosis in locally advanced rectal cancer
por: Li, Wen-Chang, et al.
Publicado: (2021)

LncRNAs Associated with Chemoradiotherapy Response and Prognosis in Locally Advanced Rectal Cancer
por: Zhang, Yiyi, et al.
Publicado: (2021)

Application of Circulating Tumor Cells and Circulating Free DNA from Peripheral Blood in the Prognosis of Advanced Gastric Cancer
por: Yu, Pengjie, et al.
Publicado: (2022)

Molecular and Kinetic Analyses of Circulating Tumor Cells as Predictive Markers of Treatment Response in Locally Advanced Rectal Cancer Patients
por: Troncarelli Flores, Bianca C., et al.
Publicado: (2019)

Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy
por: Truelsen, Christina Glismand, et al.
Publicado: (2022)

Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis
por: He, Yiping, et al.
Publicado: (2020)

The Effect of Lymph Node Harvest on Prognosis in Locally Advanced Middle-Low Rectal Cancer After Neoadjuvant Chemoradiotherapy
por: Lin, Zhuangbin, et al.
Publicado: (2022)

Prognostic stratification based on the levels of tumor-infiltrating myeloid-derived suppressor cells and PD-1/PD-L1 axis in locally advanced rectal cancer
por: Lim, Yu Jin, et al.
Publicado: (2022)

Prognosis and value of preoperative radiotherapy in locally advanced rectal signet-ring cell carcinoma
por: Ling, Chun-Run, et al.
Publicado: (2017)

The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
por: Saluja, Hariti, et al.
Publicado: (2018)

Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer
por: Corradetti, Michael N., et al.
Publicado: (2019)

Circulating Tumor DNA-Based Disease Monitoring of Patients with Locally Advanced Esophageal Cancer
por: Hofste, Lisa S. M., et al.
Publicado: (2022)

Evaluation of ctDNA in the Prediction of Response to Neoadjuvant Therapy and Prognosis in Locally Advanced Rectal Cancer Patients: A Prospective Study
por: Morais, Marina, et al.
Publicado: (2023)

Metastasis risk stratification and response prediction through dynamic viable circulating tumor cell counts for rectal cancer in a neoadjuvant setting
por: Liu, Wen‐Yang, et al.
Publicado: (2023)

Serial circulating tumour DNA analysis for locally advanced rectal cancer treated with preoperative therapy: prediction of pathological response and postoperative recurrence
por: Murahashi, Satoshi, et al.
Publicado: (2020)

Advances in the treatment of locally advanced rectal cancer
por: Ali, Fadwa, et al.
Publicado: (2020)

Advances in surgery for locally advanced rectal cancer
por: Oh, Bo Young
Publicado: (2022)

Improving on-treatment risk stratification of cancer patients with refined response classification and integration of circulating tumor DNA kinetics
por: Lv, Jiawei, et al.
Publicado: (2022)

Identification of Locally Advanced Rectal Cancer with Low Risk of Local Recurrence
por: Wang, Qiao-Xuan, et al.
Publicado: (2015)

Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses
por: van Rees, Jan M., et al.
Publicado: (2023)

Post-radiation circulating tumor DNA as a prognostic factor in locally advanced esophageal squamous cell carcinoma
por: Jia, Ru, et al.
Publicado: (2021)

Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study
por: Wang, Yaqi, et al.
Publicado: (2021)

Molecular and Dynamic Evaluation of Proteins Related to Resistance to Neoadjuvant Treatment with Chemoradiotherapy in Circulating Tumor Cells of Patients with Locally Advanced Rectal Cancer
por: Silva, Virgílio Souza e, et al.
Publicado: (2021)

Early-onset locally advanced rectal cancer characteristics, a practical nomogram and risk stratification system: a population-based study
por: Su, Yang, et al.
Publicado: (2023)

Predicting prognosis according to preoperative chemotherapy response in patients with locally advanced lower rectal cancer
por: Shiraishi, Takuya, et al.
Publicado: (2019)

Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer
por: Chiloiro, Giuditta, et al.
Publicado: (2023)

Effect of Neoadjuvant Chemoradiotherapy with Capecitabine versus Fluorouracil for Locally Advanced Rectal Cancer: A Meta-Analysis
por: Liu, Guo-Chen, et al.
Publicado: (2016)

Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignancies
por: Kirchweger, Patrick, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tjmjafo0cdfspa7efge2hja2vk